RSV infection in infants and young children. What's new in diagnosis, treatment, and prevention?
about
Induction of protective effector immunity to prevent pathogenesis caused by the respiratory syncytial virus. Implications on therapy and vaccine designAntiviral Activity of TMC353121, a Respiratory Syncytial Virus (RSV) Fusion Inhibitor, in a Non-Human Primate ModelNovel therapies and vaccines against the human respiratory syncytial virus.Epidemiologic, socioeconomic, and clinical factors associated with severity of respiratory syncytial virus infection in previously healthy infants.Apparent Life-Threatening Events (ALTE): Italian guidelines.
P2860
RSV infection in infants and young children. What's new in diagnosis, treatment, and prevention?
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
RSV infection in infants and y ...... is, treatment, and prevention?
@ast
RSV infection in infants and y ...... is, treatment, and prevention?
@en
type
label
RSV infection in infants and y ...... is, treatment, and prevention?
@ast
RSV infection in infants and y ...... is, treatment, and prevention?
@en
prefLabel
RSV infection in infants and y ...... is, treatment, and prevention?
@ast
RSV infection in infants and y ...... is, treatment, and prevention?
@en
P2860
P356
P1476
RSV infection in infants and y ...... is, treatment, and prevention?
@en
P2093
P2860
P304
97-9, 103-4, 107-8 passim
P356
10.3810/PGM.1999.12.803
P407
P577
1999-12-01T00:00:00Z